Clinical Trials Browser

Hereditary Breast and Ovarian Cancer Syndrome

NCT05677048 2026-03-09

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Ovarian Neoplasms, Pancreatic Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT04494945 2026-01-23

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Phase NA Recruiting

27,500 enrolled

BreastGastrointestinalGynecologic

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

Clinical Trials

FIMBRIECTOMIE

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

BWHS RoR

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Reborn-i

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

CHARM

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

Women at Risk of Breast Cancer and OLFM4

PC-CDS

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

TUMOSPEC

Pediatric Reporting of Adult-Onset Genomic Results

DIRECT

LIBRE

Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

LIBRE-2

Nutritional Intervention and DNA Damage of Patients With HBOC

A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer

Enhance the Use of Genetic Counseling and Testing in Latinas

Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer

Genetic Counseling for Breast Cancer Survivors (GC for BC)

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children

Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

EXSAL

Telemedicine vs. Face-to-Face Cancer Genetic Counseling

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer